William Beaumont Hospital

The trials here

What the 24 trials at this site are about, from their registry records.

Conditions

• Aortic stenosis7 trials
• Stroke4 trials
• Atrial fibrillation3 trials
• Coronary artery disease3 trials
• Osteoarthritis3 trials
• Heart failure2 trials
• Prostate cancer2 trials
• Rheumatoid arthritis2 trials
• Aortic aneurysm1 trial
• Dilated cardiomyopathy1 trial
• High blood pressure1 trial
• Triple-negative breast cancer1 trial

Phase

• Phase 34 trials
• Phase 21 trial

Status

• Active, not recruiting7 trials
• Recruiting7 trials
• Completed5 trials
• Withdrawn3 trials
• Enrolling by invitation1 trial
• Suspended1 trial

Lead sponsor

• Edwards Lifesciences4 trials
• Zimmer Biomet3 trials
• Novartis Pharmaceuticals2 trials
• Ancora Heart, Inc.1 trial
• Biosensors Europe SA1 trial
• and 13 more

Running trials

• Recruiting

  An Open-label Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan Versus Observation in PSMA Positive OMPC.

  NCT05939414· Phase 3· Novartis Pharmaceuticals· Source

  Contact: Jennifer Murray

• Recruiting

  A Multicenter Trial Assessing the Impact of Lipoprotein(a) Lowering With Pelacarsen (TQJ230) on the Progression of Calcific Aortic Valve Stenosis

  NCT05646381· Phase 2· Novartis Pharmaceuticals· Source

  Contact: Rachel Wylie

• Recruiting

  The Rhythm Evaluation for AntiCoagulaTion With Continuous Monitoring of Atrial Fibrillation

  NCT05836987· Phase 3· Johns Hopkins University· Source

  Contact: Trevia Butler

• Active, not recruiting

  A Study of Milvexian in Participants After an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack- LIBREXIA-STROKE

  NCT05702034· Phase 3· Janssen Research & Development, LLC· Source

• Recruiting

  Valve Hemodynamic Optimization Based on Doppler-Echocardiography vs Catheterization Measurements Following ViV TAVR

  NCT05459233· Institut universitaire de cardiologie et de pneumologie de Québec, University Laval· Source

  Contact: Amr Abbas

• Recruiting

  Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)

  NCT05633654· Phase 3· Gilead Sciences· Source

• Recruiting

  Zimmer Biomet Shoulder Arthroplasty PMCF

  NCT04984291· Zimmer Biomet· Source

  Contact: Cayla Lafollette, BS

• Recruiting

  Staged Complete Revascularization for Coronary Artery Disease vs Medical Management Alone in Patients With AS Undergoing Transcatheter Aortic Valve Replacement

  NCT04634240· University of British Columbia· Source

  Contact: Amr Abbas, MD

• Active, not recruiting

  CHAMPION-AF Clinical Trial

  NCT04394546· Boston Scientific Corporation· Source

• Active, not recruiting

  Post-Market Study of Comprehensive Reverse Augmented Glenoid and Mini Humeral Tray in Total Shoulder Arthroplasty

  NCT03726554· Zimmer Biomet· Source

• Recruiting

  Real-world Experience of Catheter Ablation for the Treatment of Arrhythmias

  NCT04088071· Heart Rhythm Clinical and Research Solutions, LLC· Source

  Contact: Greg Schlosser

• Active, not recruiting

  LEADERS FREE II: BioFreedom™ Pivotal Study

  NCT02843633· Biosensors Europe SA· Source

• Active, not recruiting

  Pivotal Study of MRI-guided Transurethral Ultrasound Ablation in Patients With Localized Prostate Cancer

  NCT02766543· Profound Medical Inc.· Source

• Active, not recruiting

  PARTNER 3 Trial: Safety and Effectiveness of the SAPIEN 3 Transcatheter Heart Valve in Low Risk Patients With Aortic Stenosis

  NCT02675114· Edwards Lifesciences· Source

• Enrolling by invitation

  Comprehensive Reverse Shoulder Data Collection

  NCT03404778· Zimmer Biomet· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Aortic stenosis3 recruiting
• Atrial fibrillation2 recruiting
• Coronary artery disease1 recruiting
• Osteoarthritis1 recruiting
• Prostate cancer1 recruiting
• Rheumatoid arthritis1 recruiting
• Stroke1 recruiting
• Triple-negative breast cancer1 recruiting

Closed trials

• Recruiting

  GORE® CARDIOFORM Septal Occluder and Antiplatelet Medical Management for Reduction of Recurrent Stroke in Patients With Patent Foramen Ovale (PFO): the REDUCE Post Approval Study

  NCT03821129· W.L.Gore & Associates· Source

  Contact: Tammy DeLozier

• Recruiting

  The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With FMR

  NCT03142152· Cardiac Dimensions, Inc.· Source

  Contact: Hank Hauser

• Completed

  PIONEER III Trial to Assess Safety and Efficacy of the BuMA Supreme™ Drug Coated Coronary Stent in Patients With Coronary Disease

  NCT03168776· Sino Medical Sciences Technology Inc.· Source

• Recruiting

  PARTNER 3 Trial - Aortic Valve-in-Valve

  NCT03003299· Edwards Lifesciences· Source

  Contact: Edwards THV Clinical Affairs

• Completed

  Carotid Revascularization and Medical Management for Asymptomatic Carotid Stenosis Trial

  NCT02089217· Mayo Clinic· Source

• Completed

  PARTNER II Trial: Placement of AoRTic TraNscathetER Valves II - S3 Intermediate

  NCT03222128· Edwards Lifesciences· Source

• Completed

  ANCHOR (Aneurysm Treatment Using the Heli-FX™ EndoAnchor™ System Global Registry)

  NCT01534819· Medtronic Cardiovascular· Source

• Completed

  PARTNER II Trial: Placement of AoRTic TraNscathetER Valves II - XT Intermediate and High Risk

  NCT01314313· Edwards Lifesciences· Source